Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases
- Conditions
- Bone Metastases
- Interventions
- Diagnostic Test: PET/MR
- Registration Number
- NCT04159376
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Brief Summary
The great promise of PET/MR for assessment of skeletal metastatic involvement is derived from the extensive experience with stand- alone MR, but initial data on the use of PET/MR for assessment of bone pathology indicate that PET/MR introduces unique issues that should be addressed when determining its role in this clinical scenario.
In this study cohort includes 150 patients 18 years or older, having metastatic skeletal involvement on baseline PET/CT prior to treatment. Baseline studies and follow up studies of the patients referred post treatment, will be reviewed.
The main goal of the study is to asses the accuracy of PET/MR in detection and monitoring response of bone metastases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
150 patients having metastatic skeletal involvement on baseline PET/CT prior to treatment
- Age <18.
- Pregnant or breast feeding patients.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Bone Metastases Patients PET/MR -
- Primary Outcome Measures
Name Time Method The investigators will report about the number of patients who preformed PET/MR for assessment of skeletal involvement as well as activity after treatment, 1 year and also preformed in routine PET/CT and to optimize the algorithm of MR-based attenuated PET images.
- Secondary Outcome Measures
Name Time Method